Navigation Links
National Drug Development Accelerator Launched
Date:11/20/2008

LENEXA, Kan., Nov. 20 /PRNewswire/ -- KansasBio announced today a bioscience cluster activation initiative to promote the region's human health-care-related bioscience companies that serve the entire drug development continuum. Called the National Drug Development Accelerator (the Accelerator), the alliance comprises companies across Kansas and the Kansas City metropolitan area that represent many of the nation's preferred resources for drug development.

KansasBio says the Accelerator offers a full spectrum of drug development services. From discovery to post market, the alliance of companies offers comprehensive assets to bring pharmaceuticals and biotech drugs to market cost effectively and at a high level of quality.

"Kansas' collection of companies is the answer to the emerging outsourcing trend among pharmaceutical companies," said Angela Kreps, president of KansasBio. "During the last 5 years as pharmaceutical companies have increased outsourcing, and when development budgets are enduring additional scrutiny related to return on investment, our companies are busy bringing the biggest new drugs to market. We will continue to define the value proposition in a tenuous economy."

In the drug development process, where saving one day can mean saving millions of dollars, Kansas service providers have advanced clinical timelines to save pharmaceutical partners days and sometimes weeks. KansasBio cites local companies' responsiveness as one reason that there are 1,950 ongoing clinical trials in the Kansas region -- the fifth highest per capita in the United States. In areas of the state, the number of clinical trials providing access to new treatments has more than doubled during the last 4 years, according to KansasBio.

"The Kansas region has a 30-year history of expertise with the capabilities to go from the chemistry bench to the patient's bedside," said Michael Beckloff, president of Beckloff Associates. "Our cluster represents companies that have helped develop more than 50 of the world's top drugs. We can efficiently move drugs through the development pipeline and help pharmaceutical companies maximize market years and return on investment."

Kansas has a decades-long history of drug development and is home to preferred partners for major pharmaceutical companies. The state has one of the region's greatest geographic concentrations of experienced pharmaceutical development, clinical research and bioscience companies. To learn more about the Accelerator, visit http://www.NDDAccelerator.com.


'/>"/>
SOURCE KansasBio
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Brazilian National Biosafety Technical Committee Approves Monsanto Company Insect-Protected Corn Trait
2. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
3. Michael Troullis Appointed Chief Financial Officer of Quintiles Transnational Corp.
4. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
5. The Government of Quebec and the New Canadian Government Invest in the Creation of an International Biobank
6. International Isotopes Inc. Announces Completion of an Exclusive Distributor Agreement for Sales of New Style Transportation Containers
7. Arrow International Files and Mails Definitive Proxy Materials
8. Niceware International Announces Licensed Vendor Status with ICCBBA, Inc. to Provide ISBT 128-compliant Software
9. DuPont, Genencor International and Tate & Lyle Honored for Groundbreaking Work in Developing Bio-PDO(TM)
10. Viragen International to Reverse Split Its Common Stock
11. Tutogen Medical, Inc. and Zimmer Holdings, Inc. Announce Agreement for International Distribution of Biological Products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... and LAGUNA HILLS, Calif. , Oct. ... Cancer Research, London (ICR) and University ... SKY92, SkylineDx,s prognostic tool to risk-stratify patients with multiple myeloma ... MUK nine . The University of Leeds ... partly funded by Myeloma UK, and ICR will perform the ...
(Date:10/10/2017)... ... 2017 , ... San Diego-based team building and cooking events company, Lajollacooks4u, has ... The bold new look is part of a transformation to increase awareness, appeal to ... period. , It will also expand its service offering from its signature gourmet cooking ...
(Date:10/10/2017)... 10, 2017 International research firm Parks Associates announced ... at the TMA 2017 Annual Meeting , October 11 in ... residential home security market and how smart safety and security products impact ... Parks Associates: Smart Home ... "The residential security market has ...
(Date:10/9/2017)... DIEGO , Oct. 9, 2017  BioTech ... biological mechanism by which its ProCell stem cell ... critical limb ischemia.  The Company, demonstrated that treatment ... amount of limbs saved as compared to standard ... the molecule HGF resulted in reduction of therapeutic ...
Breaking Biology Technology:
(Date:3/28/2017)... , March 28, 2017 The ... Hardware (Camera, Monitors, Servers, Storage Devices), Software (Video Analytics, ... Region - Global Forecast to 2022", published by MarketsandMarkets, ... 2016 and is projected to reach USD 75.64 Billion ... and 2022. The base year considered for the study ...
(Date:3/24/2017)... 24, 2017 The Controller General of Immigration from ... Abdulla Algeen have received the prestigious international IAIR Award for the ... Continue Reading ... ... Controller Abdulla Algeen (small picture on the right) have received the IAIR ...
(Date:3/23/2017)... The report "Gesture Recognition and Touchless Sensing Market by Technology (Touch-based ... to 2022", published by MarketsandMarkets, the market is expected to be worth USD ... 2022. Continue Reading ... ... ...
Breaking Biology News(10 mins):